Suture stem cells and AI-enabled multi-omics in craniosynostosis: from niche biology to regenerative medicine

Craniosynostosis, the premature fusion of cranial sutures, affects approximately 1 in 2,100–2,500 live births and remains exclusively treated by surgery, which carries risks of resynostosis, secondary intracranial hypertension, and neurodevelopmental sequelae. Over the past decade, the cranial suture has been redefined from a passive fibrous joint into a dynamic stem cell niche: mesenchymal stem and progenitor populations marked by Gli1, Axin2, and Prrx1 reside within the suture mesenchyme, sustain calvarial bone homeostasis, and are depleted or dysregulated in craniosynostosis. In parallel, single-cell RNA sequencing, spatial transcriptomics, and single-nucleus epigenomics have produced the first high-resolution atlases of suture development in mouse and human, while machine learning and deep learning methods increasingly shape diagnosis, phenotyping, and data integration. This review synthesizes these converging lines of evidence for a pediatric neurosurgery and regenerative medicine audience. We first describe the cellular and molecular architecture of the suture stem cell niche and its disruption in syndromic and nonsyndromic craniosynostosis. We then review how multi-omics technologies—single-cell transcriptomics, spatial profiling, and chromatin accessibility mapping—are resolving suture cell states, developmental trajectories, and niche interactions, and how artificial intelligence (AI) methods, from variational autoencoders and trajectory inference to gene regulatory network and cell–cell communication models, convert these data into mechanistic hypotheses. We next examine translational progress, including stem cell-based suture regeneration, biomaterial niche engineering, and patient-derived iPSC disease models, and discuss how AI-assisted biomarker discovery, potency prediction, and quality control could support future cell-based interventions. Finally, we outline outstanding challenges—model interpretability, cross-species and cross-dataset transferability, data standards, and the experimental validation of AI-derived predictions—that must be addressed to move toward reliable regenerative strategies for craniosynostosis.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-20
DOI
https://doi.org/10.3389/fcell.2026.2010122
Primary Topic
Craniofacial Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Suture stem cells and AI-enabled multi-omics in craniosynostosis: from niche biology to regenerative medicine

Min Wei, Yingxue Song, Lingzhao Min, Meiling Liu et al.
2 links
Frontiers in Cell and Developmental Biology
Craniofacial Disorders and Treatments
article

Suture stem cells and AI-enabled multi-omics in craniosynostosis: from niche biology to regenerative medicine

Min Wei, Yingxue Song, Lingzhao Min, Meiling Liu, Jinwei Li, Xiaoqiang Wang
article en

Abstract

Craniosynostosis, the premature fusion of cranial sutures, affects approximately 1 in 2,100–2,500 live births and remains exclusively treated by surgery, which carries risks of resynostosis, secondary intracranial hypertension, and neurodevelopmental sequelae. Over the past decade, the cranial suture has been redefined from a passive fibrous joint into a dynamic stem cell niche: mesenchymal stem and progenitor populations marked by Gli1, Axin2, and Prrx1 reside within the suture mesenchyme, sustain calvarial bone homeostasis, and are depleted or dysregulated in craniosynostosis. In parallel, single-cell RNA sequencing, spatial transcriptomics, and single-nucleus epigenomics have produced the first high-resolution atlases of suture development in mouse and human, while machine learning and deep learning methods increasingly shape diagnosis, phenotyping, and data integration. This review synthesizes these converging lines of evidence for a pediatric neurosurgery and regenerative medicine audience. We first describe the cellular and molecular architecture of the suture stem cell niche and its disruption in syndromic and nonsyndromic craniosynostosis. We then review how multi-omics technologies—single-cell transcriptomics, spatial profiling, and chromatin accessibility mapping—are resolving suture cell states, developmental trajectories, and niche interactions, and how artificial intelligence (AI) methods, from variational autoencoders and trajectory inference to gene regulatory network and cell–cell communication models, convert these data into mechanistic hypotheses. We next examine translational progress, including stem cell-based suture regeneration, biomaterial niche engineering, and patient-derived iPSC disease models, and discuss how AI-assisted biomarker discovery, potency prediction, and quality control could support future cell-based interventions. Finally, we outline outstanding challenges—model interpretability, cross-species and cross-dataset transferability, data standards, and the experimental validation of AI-derived predictions—that must be addressed to move toward reliable regenerative strategies for craniosynostosis.

Frontiers in Cell and Developmental BiologyVol. 14
Shanghai Jiao Tong University (CN), XinHua Hospital (CN)
Good health and well-being
Craniofacial Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon